Monoclonal antibodies against HMGB1

Details for Australian Patent Application No. 2004272607 (hide)

Owner Critical Therapeutics, Inc.

Inventors Newman, Walter; Qin, Shixin; Obar, Robert; O'Keefe, Theresa

Agent Davies Collison Cave

Pub. Number AU-B-2004272607

PCT Pub. Number WO2005/026209

Priority 60/502,568 11.09.03 US

Filing date 10 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 6 November 2008

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/026209 Priority application(s): WO2005/026209

6 November 2008 Application Accepted

  Published as AU-B-2004272607

5 February 2009 Alteration of Name

  The name of the applicant has been altered to Cornerstone Therapeutics Inc. Amendments 2005

5 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272628-Exhaust muffler

2004272605-Fuel drip prevention method